These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 543767)

  • 1. Tissue specificity of calcium-antagonistic properties of lidoflazine.
    Van Nueten JM; Wellens D
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):329-31. PubMed ID: 543767
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of the Ca2+ antagonist lidoflazine on normoxic and anoxic contractions of canine coronary arterial smooth muscle.
    van Nueten JM; Vanhoutte PM
    Eur J Pharmacol; 1980 Jun; 64(2-3):173-6. PubMed ID: 7398761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+.
    Ravens U; Liu GS; Vandeplassche G; Borgers M
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):47-58. PubMed ID: 1576096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial reoxygenation damage. Can it be circumvented?
    Chappell SP; Lewis MJ; Henderson AH
    Adv Myocardiol; 1985; 6():585-92. PubMed ID: 3992051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of cinnarizine on the contraction induced by calcium in depolarized arterial and intestinal smooth muscle preparations.
    Godfraind T; Kaba A; Van Dorsser W
    Arch Int Pharmacodyn Ther; 1972 Jun; 197(2):399-400. PubMed ID: 4402302
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of lidoflazine on membrane currents and contraction in voltage-clamped frog atrial fibers.
    Einwächter HM; Kern R; Herb J
    Eur J Pharmacol; 1979 May; 55(3):225-32. PubMed ID: 313339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique.
    Borgers M; Thoné F; van Nueten JM
    Acta Histochem Suppl; 1981; 24():327-32. PubMed ID: 6165047
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of lidoflazine and flunarizine on cerebral reactive hyperemia.
    Phillis JW; DeLong RE; Towner JK
    Eur J Pharmacol; 1985 Jun; 112(3):323-9. PubMed ID: 4018140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravenous lidoflazine on serotonin-induced cerebral vascular contraction--an in vivo study.
    Rosenwasser RH; Tuma RF; Buchheit WA
    Stroke; 1986; 17(4):728-30. PubMed ID: 3738957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of lidoflazine, trapymin, and nifedipine on miocardial and other rat tissue blood flow (author's transl)].
    Kapitola J; Petrásek J; Vilimovská D
    Cas Lek Cesk; 1977 Aug; 116(31):957-63. PubMed ID: 902298
    [No Abstract]   [Full Text] [Related]  

  • 12. Electromechanical dissociation after ventricular fibrillation: prevention with calcium-entry blockers.
    Vincent JL; Goldstein J; Dufaye P; Domb M
    J Cardiovasc Pharmacol; 1984; 6(6):1124-31. PubMed ID: 6084770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine.
    Rosenthal RE; Hamud F; Fiskum G; Varghese PJ; Sharpe S
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):752-8. PubMed ID: 3693430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some effects of dipyridamole, hexobendine and lidoflazine on inhibitory processes in rabbit duodenum.
    Hulme ME; Weston AH
    Br J Pharmacol; 1974 Apr; 50(4):609-11. PubMed ID: 4447864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on lidoflazine (R-7904).
    Türker RK; Kayaalp SO; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1209-12. PubMed ID: 4387885
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).
    Kazda S; Garthoff B; Meyer H; Schlossmann K; Stoepel K; Towart R; Vater W; Wehinger E
    Arzneimittelforschung; 1980; 30(12):2144-62. PubMed ID: 7194077
    [No Abstract]   [Full Text] [Related]  

  • 17. The action of flunarizine and lidoflazine on isoprenaline induced cardiac lesions.
    Godfraind T; Khouri G; Sturbois X
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):330-2. PubMed ID: 7406590
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle.
    Van Nueten JM; Van Beek J; Janssen PA
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):42-52. PubMed ID: 666459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides.
    Fleckenstein A; Byon KY
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R20. PubMed ID: 4276541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of lidoflazine on sinoventricular conduction].
    Chauvin M; Giudicelli JF
    Nouv Presse Med; 1978 Sep; 7(32):2874. PubMed ID: 714675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.